The content provided in this video is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All views expressed are those of InsightfulValue and are based on publicly available information believed to be reliable, but no guarantee is made as to its accuracy or completeness. Always conduct your own research or consult a licensed financial advisor before making any investment decisions. Investing in the stock market involves risks, including the loss of principal.
Please be aware that the stock prices displayed on this website represent a curated selection of data. On desktop devices, you will see a wider range of stock prices, while on mobile devices, we provide a more streamlined view for better user experience and readability.
Our focus is on assessing a company's overall value and performance, rather than analyzing price fluctuations, even if we do watch prices in order to find companies trading below their intrinsic value. For more detailed charting and comprehensive market analysis, we recommend consulting a professional financial service or utilizing advanced charting tools.
We strive to provide accurate and timely information, but we encourage you to verify any financial data before making investment decisions.
Overview
Becton Dickinson and Company (BD) is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD was founded in 1897 by Maxwell Becton and Fairleigh Dickinson and is headquartered in Franklin Lakes, New Jersey, USA. The company's products are used in various healthcare settings such as hospitals, clinics, laboratories, and pharmacies, to improve patient care and help healthcare professionals diagnose and treat diseases. BD's main areas of focus include diagnostic systems, medication delivery solutions, and biosciences. BD has a presence in over 190 countries and employs more than 70,000 people worldwide. The company has a global reach in both developed and emerging markets, with a diverse product portfolio and a strong research and development pipeline. BD is committed to enhancing healthcare outcomes through innovation and collaboration with healthcare professionals, patients, and healthcare systems. The company aims to make a positive impact on the future of healthcare by providing safe, effective, and high-quality medical products and services. In addition, BD has a strong commitment to corporate social responsibility and sustainability. The company focuses on initiatives related to improving access to healthcare, reducing its environmental footprint, and promoting ethical business practices. Overall, BD is a leading company in the medical technology industry, with a long history of innovation and a strong dedication to improving healthcare outcomes globally.
What is special about the company?
π Want to read more about Becton Dickinson and Company?
The sensitivity of Becton Dickinson and Companyβs earnings, cash flow, and valuation to changes in interest rates can be analyzed from several perspectives: 1. Earnings Sensitivity: Interest rates can impact earnings primarily through their influence on borrowing costs and capital expenditure decisions. If interest rates rise, the cost of servicing debt increases, potentially squeezing profit margins. Additionally, higher rates can lead to reduced consumer and institutional spending on medical devices, which could adversely affect sales growth. Conversely, lower interest rates may stimulate borrowing and investment in growth, benefiting earnings overall. 2. Cash Flow Sensitivity: Cash flow from operations may not be as directly affected by interest rates as earnings, but there are still clear connections. Higher interest rates can increase interest expense if the company has variable-rate debt, which can reduce free cash flow. Furthermore, if higher rates result in decreased demand for products, cash inflows may decline. On the other hand, lower interest rates generally facilitate stronger cash flows by reducing financing costs and encouraging investment. 3. Valuation Sensitivity: Valuation of publicly traded companies like Becton Dickinson is often conducted using discounted cash flow (DCF) analysis, where future cash flows are discounted back to their present value using a discount rate that includes the risk-free rate, which tends to rise and fall with changes in interest rates. When interest rates increase, the present value of future cash flows decreases, leading to a lower valuation. This can impact investment sentiment and stock price in the market. In summary, Becton Dickinson and Companyβs earnings, cash flow, and valuation are sensitive to changes in interest rates. Rising rates can lead to increased costs and lower valuations, while falling rates may have a positive impact by lowering expenses and fostering growth. Managementβs ability to navigate these changes will play a critical role in mitigating risks associated with interest rate fluctuations.
Interesting facts about the company
π Want to read more about Becton Dickinson and Company?
π InsightfulValue is a platform for public company analysis.
π We provide a database of public companies, with a focus on value investing principles.
π We carefully select every company in our database. With only 1809 listed, there's a reason for that.
π The reason is simple β we only select the best-performing public companies, true champions. And we know exactly what we mean by "champion."
π For us, a champion is a company with strong finances, a history of impressive dividends, great management, and standout products or services. We mean it.
π For each company, we have 570 questions and answers covering every aspect of their market position and operations. Everything.
π ... plus additional 121 Q&A about the industry each company operates in.
InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations. Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site. By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.